Related Experiment Video
Updated: Feb 19, 2026

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Conducting clinical trials in supportive and palliative oncology: challenges and opportunities
David Hui1,2,3, Eduardo Bruera1
1Department of Palliative, Rehabilitation and Integrative Medicine.
Purpose Of Review:
High-quality research is essential to enhance the delivery and outcomes of supportive care for patients with cancer. In this review, we discuss key challenges and potential solutions for conducting supportive care clinical trials in oncology.
Recent Findings:
Structural barriers to supportive care research include limited infrastructure and investigators, insufficient funding, a paucity of foundational research, and a lack of standardized terminologies. Process barriers involve challenges in patient recruitment and retention, intervention design, control selection, and outcome assessments. Recognition of these barriers enables the development of targeted strategies to overcome them. Encouragingly, there is growing awareness of the importance of supportive care among investigators, clinicians, patients, and healthcare administrators, leading to an increase in research activity, funding, and publications. Research centers and professional organizations dedicated to supportive care are actively building capacity and fostering collaboration. Additionally, innovative study designs, personalized outcome measures, and multicenter research networks offer promising strategies to enhance both the quantity and quality of clinical trials.
Summary:
Through interdisciplinary collaborations, we can continue to strengthen the infrastructure and refine the processes in supportive care trials. These efforts will help build a robust evidence base and ultimately improve outcomes for patients with cancer.
More Related Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Preclinical Development: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...